wego semaglutide Wegovy sales took a hit this year. Novo's CEO blames off-brand competition Losing weight and keeping it off can lessen the many health risks that come with obesity Novo Nordisk has launched its

Weight loss specialists generally avoid this combination due to safety risks and lack of clinical trial data supporting its use

Of the patients who took semaglutide and then developed NAION, those aged 40 to 64 (HR=3.31), who were female (HR=3.24), who were white (HR=2.34) or who had hypertension (HR=2.42) were more likely to be affected

Macrolides like azithromycin and the strong antibiotic vancomycin can also affect hearing

NK, natural killer

In other words, the gut microbiota and the host may have evolved with each other to produce mutually beneficial outcomes

Weight-related progress depends on medical history, eligibility, dose, nutrition, activity level, follow-up care, and provider monitoring